Post Articles – Topics of Many Interests

Non Hodgkin Lymphoma survival rate differ extensively. It depends on different variables such as the lymphoma type, stage, age of the patient, and others. In general, according to the American Cancer Society, the 5-year survival rate of people who have Non-Hodgkin Lymphoma is 63%, higher compared to the 10-year survival rate, which is only 51%. The survival rate is the approximation of the probability when a patient can survive a certain period of time after diagnosis. It is calculated excluding other fatal diseases other than cancer.

A definite prognosis for Non-Hodgkin Lymphoma survival rate is very difficult to calculate because the outlook has a lot of variables. If the cancer is detected at an early stage, there are higher chances of surviving for many years but those who are diagnosed when the cancer already spread, the survival rate is reduced. Aggressive lymphomas can devastate the body faster causing hasty death however there is still hope because this illness is curable.

Advances in medical technology and breakthroughs in research has improved Non Hodgkin Lymphoma survival rate. Particularly to those who are under the age of 45, the progresses in treatments improved over the past 20 years.

Follicular lymphoma is the most common indolent Non Hodgkin Lymphoma. They are potentially curable at stages 1 and 2, unfortunately it is very hard to detect and by the time it is diagnosed, it is already in the advanced stages. This kind of Non Hodgkin Lymphoma survival rate by and large is at 7-10 years, depending on other risk factors. In addition, new drug treatments boasts to considerably increased the survival rates.

High grade aggressive lymphomas may be diagnosed at once because it is symptomatic even if it is still in the early stages. They are possible to be cured by belligerent treatments. Diffuse b-cell lymphoma seems to be the most ordinary aggressive Non Hodgkin Lymphoma but it can be deadly if ignored and not treated immediately, treatments for this are combination of exhaustive chemotherapy. This type of Non Hodgkin Lymphoma survival rate depends on five risk factors. The five factors are: a) being older than 60, b) having a disseminated tumor (stage 3 and 4), c) disease that spread more than one site beyond the lymph nodes, d) patient’s functional ability and finally e) having elevated levels of the lactate dehydrogenase (LDH) protein. If the patient has none of the risk factors, then outlook is positive and good, while having two factors indicate a low-to intermediate poor outlook, three factors predict an intermediate to high likelihood of poor outlook while if one has all the risk factors, the Non Hodgkin Lymphoma survival rate is very poor.

There are still advances in technology that can improve Non Hodgkin Lymphoma survival rate, all it takes is optimism and a lot of vigilance.

Tweet

Article comments are closed.